{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T12:43:29Z","timestamp":1709556209842},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T00:00:00Z","timestamp":1610582400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T00:00:00Z","timestamp":1610582400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Key Project Sub-Project of Pediatric Collaborative Center of Beijing Hospital Authority","award":["XTZD20180203"],"award-info":[{"award-number":["XTZD20180203"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>To analyze the clinical characteristics, treatment and prognosis of children with unilateral retinoblastoma (RB) and intracranial segment of retrobulbar optic nerve invasion.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A total of 14 children with unilateral RB and intracranial segment of retrobulbar optic nerve invasion were enrolled in this retrospective study from January 2009 to December 2018. Clinical characteristics, treatment and prognosis were collected and analyzed. Survival curves were calculated by Kaplan-Meier method.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Of 14 cases, there were 7 male and 7 female, ranging in age from 22.85 to 121.97\u2009months (median, 41.03\u2009months). Seventy-one percent of patients came from first-tier cities in China and effected in the left eye. Magnetic resonance imaging (MRI) results indicated that all patients presented with thickened and enhanced optic nerve and intracranial segment of optic nerve invasion. Nine patients received comprehensive therapeutic regimen (chemotherapy, eye enucleation, radiotherapy and intrathecal therapy). The patients were followed up to December 2019, with a median follow-up of 20.6\u2009months. The median disease specific survival was 48.99\u2009\u00b1\u20098.62\u2009months, and the overall survival (OS) rate was 64.3%. Radiotherapy and comprehensive therapeutic regimen had significant impact on survival time (all <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The overall prognosis of unilateral RB patients with intracranial segment of retrobulbar optic nerve invasion was poor. Chemotherapy and surgical treatment were necessary, but more attention should be paid to radiotherapy and intrathecal therapy for improving prognosis.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12886-020-01768-4","type":"journal-article","created":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T11:03:19Z","timestamp":1610622199000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Clinical characteristics, treatment and prognosis of children with unilateral retinoblastoma and intracranial segment of Retrobulbar optic nerve invasion"],"prefix":"10.1186","volume":"21","author":[{"given":"Yi-Zhuo","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-Sheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji-Tong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-Min","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Lin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua-Li","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,14]]},"reference":[{"issue":"12","key":"1768_CR1","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1038\/s41388-017-0050-x","volume":"37","author":"ID Fabian","year":"2018","unstructured":"Fabian ID, Onadim Z, Karaa E, Duncan C, Chowdhury T, Scheimberg I, Ohnuma SI, Reddy MA, Sagoo MS. The management of retinoblastoma. Oncogene. 2018;37(12):1551\u201360.","journal-title":"Oncogene"},{"key":"1768_CR2","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1750-1172-1-31","volume":"1","author":"I Aerts","year":"2006","unstructured":"Aerts I, Lumbroso-Le Rouic L, Gauthier-Villars M, Brisse H, Doz F, Desjardins L. Retinoblastoma. Orphanet J Rare Dis. 2006;1:31.","journal-title":"Orphanet J Rare Dis"},{"issue":"12","key":"1768_CR3","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1007\/s12098-017-2395-0","volume":"84","author":"R Rao","year":"2017","unstructured":"Rao R, Honavar SG. Retinoblastoma. Indian J Pediatr. 2017;84(12):937\u201344.","journal-title":"Indian J Pediatr"},{"issue":"2","key":"1768_CR4","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1177\/0883073815587943","volume":"31","author":"MV Ortiz","year":"2016","unstructured":"Ortiz MV, Dunkel IJ. Retinoblastoma. J Child Neurol. 2016;31(2):227\u201336.","journal-title":"J Child Neurol"},{"issue":"4","key":"1768_CR5","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1136\/bjophthalmol-2013-304321","volume":"98","author":"B Chawla","year":"2014","unstructured":"Chawla B, Khurana S, Sen S, Sharma S. Clinical misdiagnosis of retinoblastoma in Indian children. Br J Ophthalmol. 2014;98(4):488\u201393.","journal-title":"Br J Ophthalmol"},{"issue":"42","key":"1768_CR6","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000005204","volume":"95","author":"J Gao","year":"2016","unstructured":"Gao J, Zeng J, Guo B, He W, Chen J, Lu F, Chen D. Clinical presentation and treatment outcome of retinoblastoma in children of South Western China. Medicine (Baltimore). 2016;95(42):e5204.","journal-title":"Medicine (Baltimore)"},{"issue":"65","key":"1768_CR7","doi-asserted-by":"publisher","first-page":"108492","DOI":"10.18632\/oncotarget.18174","volume":"8","author":"L Jin","year":"2017","unstructured":"Jin L, Zhang W, Pan H, Li T, Liu B, Zhao J, Wang B. Retrospective investigation of retinoblastoma in Chinese patients. Oncotarget. 2017;8(65):108492\u20137.","journal-title":"Oncotarget"},{"issue":"4","key":"1768_CR8","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1016\/j.bbrc.2017.01.134","volume":"497","author":"W Shang","year":"2018","unstructured":"Shang W, Yang Y, Zhang J, Wu Q. Long noncoding RNA BDNF-AS is a potential biomarker and regulates cancer development in human retinoblastoma. Biochem Biophys Res Commun. 2018;497(4):1142\u20138.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"1768_CR9","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s12886-018-0772-8","volume":"18","author":"H Hu","year":"2018","unstructured":"Hu H, Zhang W, Wang Y, Huang D, Shi J, Li B, Zhang Y, Zhou Y. Characterization, treatment and prognosis of retinoblastoma with central nervous system metastasis. BMC Ophthalmol. 2018;18(1):107.","journal-title":"BMC Ophthalmol"},{"key":"1768_CR10","doi-asserted-by":"publisher","first-page":"15021","DOI":"10.1038\/nrdp.2015.21","volume":"1","author":"H Dimaras","year":"2015","unstructured":"Dimaras H, Corson TW, Cobrinik D, White A, Zhao J, Munier FL, Abramson DH, Shields CL, Chantada GL, Njuguna F, et al. Retinoblastoma. Nat Rev Dis Primers. 2015;1:15021.","journal-title":"Nat Rev Dis Primers"},{"issue":"6","key":"1768_CR11","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1002\/pbc.20606","volume":"47","author":"G Chantada","year":"2006","unstructured":"Chantada G, Doz F, Antoneli CB, Grundy R, Clare Stannard FF, Dunkel IJ, Grabowski E, Leal-Leal C, Rodr\u00edguez-Galindo C, Schvartzman E, et al. A proposal for an international retinoblastoma staging system. Pediatr Blood Cancer. 2006;47(6):801\u20135.","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"1768_CR12","doi-asserted-by":"publisher","first-page":"3016","DOI":"10.1002\/jcp.26070","volume":"233","author":"K Golabchi","year":"2018","unstructured":"Golabchi K, Soleimani-Jelodar R, Aghadoost N, Momeni F, Moridikia A, Nahand JS, Masoudifar A, Razmjoo H, Mirzaei H. MicroRNAs in retinoblastoma: potential diagnostic and therapeutic biomarkers. J Cell Physiol. 2018;233(4):3016\u201323.","journal-title":"J Cell Physiol"},{"issue":"12","key":"1768_CR13","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.4103\/ijo.IJO_1611_18","volume":"67","author":"U Kim","year":"2019","unstructured":"Kim U, Rathi G, Chowdhary G, Srinavasan KG, Shanthi R, Krishna RSP. Accuracy of preoperative imaging in predicting optic nerve invasion in retinoblastoma: a retrospective study. Indian J Ophthalmol. 2019;67(12):2019\u201322.","journal-title":"Indian J Ophthalmol"},{"issue":"9824","key":"1768_CR14","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1016\/S0140-6736(11)61137-9","volume":"379","author":"H Dimaras","year":"2012","unstructured":"Dimaras H, Kimani K, Dimba EA, Gronsdahl P, White A, Chan HS, Gallie BL. Retinoblastoma. Lancet (London, England). 2012;379(9824):1436\u201346.","journal-title":"Lancet (London, England)"},{"issue":"3 Pt 1","key":"1768_CR15","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/S0022-3476(98)70028-9","volume":"132","author":"DH Abramson","year":"1998","unstructured":"Abramson DH, Frank CM, Susman M, Whalen MP, Dunkel IJ, Boyd NW 3rd. Presenting signs of retinoblastoma. J Pediatr. 1998;132(3 Pt 1):505\u20138.","journal-title":"J Pediatr"},{"issue":"2","key":"1768_CR16","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1097\/IAE.0000000000001962","volume":"39","author":"S Kaliki","year":"2019","unstructured":"Kaliki S, Patel A, Iram S, Ramappa G, Mohamed A, Palkonda VAR. RETINOBLASTOMA IN INDIA: Clinical Presentation and Outcome in 1,457 Patients (2,074 Eyes). Retina (Philadelphia, Pa). 2019;39(2):379\u201391.","journal-title":"Retina (Philadelphia, Pa)"},{"issue":"12","key":"1768_CR17","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1136\/bjo.83.12.1320","volume":"83","author":"AG Goddard","year":"1999","unstructured":"Goddard AG, Kingston JE, Hungerford JL. Delay in diagnosis of retinoblastoma: risk factors and treatment outcome. Br J Ophthalmol. 1999;83(12):1320\u20133.","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"1768_CR18","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1177\/107327481602300203","volume":"23","author":"PR Mendoza","year":"2016","unstructured":"Mendoza PR, Grossniklaus HE. Therapeutic options for retinoblastoma. Cancer Control. 2016;23(2):99\u2013109.","journal-title":"Cancer Control"},{"issue":"6","key":"1768_CR19","doi-asserted-by":"publisher","first-page":"e335","DOI":"10.1097\/MPH.0000000000000141","volume":"36","author":"EM Sullivan","year":"2014","unstructured":"Sullivan EM, Wilson MW, Billups CA, Wu J, Merchant TE, Brennan RC, Haik BG, Shulkin B, Free TM, Given V, et al. Pathologic risk-based adjuvant chemotherapy for unilateral retinoblastoma following enucleation. J Pediatr Hematol Oncol. 2014;36(6):e335\u201340.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"9","key":"1768_CR20","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1016\/j.ophtha.2006.03.039","volume":"113","author":"K Gunduz","year":"2006","unstructured":"Gunduz K, Muftuoglu O, Gunalp I, Unal E, Tacyildiz N. Metastatic retinoblastoma clinical features, treatment, and prognosis. Ophthalmology. 2006;113(9):1558\u201366.","journal-title":"Ophthalmology"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-020-01768-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12886-020-01768-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-020-01768-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T11:05:34Z","timestamp":1610622334000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-020-01768-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,14]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1768"],"URL":"https:\/\/doi.org\/10.1186\/s12886-020-01768-4","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,14]]},"assertion":[{"value":"7 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the ethics committee of the Beijing Tongren Hospital, Capital Medical University (number, TRECKY2019\u2013034). Written informed consent was obtained from all participants and their guardians.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"38"}}